The complement system, a part of the immune system, is overactive in people with active ANCA-associated vasculitis (AAV),…
Articles by Marisa Wexler, MS
The presence of detectable ANCA antibodies and B-cells after initial treatment with rituximab — used to induce…
The complement system, a component of the immune system, is overactive in people with necrotizing glomerulonephritis, or inflammation…
Fingolimod (FTY720), a medication used to treat multiple sclerosis, also appears to ease many of the symptoms of…
Clinical trials testing new treatments for people with ANCA-associated vasculitis (AAV) need more uniformity in the patients they recruit…
People with ANCA-associated vasculitis (AAV) who have kidney involvement when they are diagnosed are more likely to experience major…
Guidelines for using rituximab as a maintenance therapy in adults with ANCA-associated vasculitis (AAV) were recently published that,…
Continuing maintenance treatment with rituximab for long periods increases the likelihood that people with ANCA-associated vasculitis (AAV) remain…
In people with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), central nervous system involvement is associated with more active disease…
Plasma exchange does not improve survival or prevent serious kidney disease in people with ANCA vasculitis, a study found.